Reduction in the COVID-19 pneumonia case fatality rate by silver nanoparticles: A randomized case study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has devastated mankind. To date, no approved treatment is available to completely combat this disease. Although many studies reported the potential of silver nanoparticles’ (AgNPs) action...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieler, Laura, Vittos, Oana, Mukherjee, Nirmalya, Sarkar, Subhasish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008037/
https://www.ncbi.nlm.nih.gov/pubmed/36942214
http://dx.doi.org/10.1016/j.heliyon.2023.e14419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008037/
https://www.ncbi.nlm.nih.gov/pubmed/36942214
http://dx.doi.org/10.1016/j.heliyon.2023.e14419

Ejemplares similares